Acorda Therapeutics Inc organizacji EBITDA
Jaka jest wartość EBITDA organizacji Acorda Therapeutics Inc?
Wartość EBITDA organizacji Acorda Therapeutics Inc to -$4.08
Jaka jest definicja EBITDA?
EBITDA to zysk firmy przed odliczeniem odsetek, podatków, amortyzacji i jest miarą księgową obliczoną na podstawie zarobków netto firmy, przed odliczeniem kosztów odsetek, podatków, amortyzacji i odliczeniem, jako wskaźnika bieżącej rentowności operacyjnej spółki.
Although EBITDA is not a financial measure recognized in generally accepted accounting principles, it is widely used in many areas of finance when assessing the performance of a company, such as securities analysis. It is intended to allow a comparison of profitability between different companies, by discounting the effects of interest payments from different forms of financing (by ignoring interest payments), political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill). EBITDA is a financial measurement of cash flow from operations that is widely used in mergers and acquisitions of small businesses and businesses in the middle market. It is not unusual for adjustments to be made to EBITDA to normalize the measurement allowing buyers to compare the performance of one business to another.
EBITDA firm w Health Care sektor na NASDAQ w porównaniu do Acorda Therapeutics Inc
Czym się zajmuję organizacja Acorda Therapeutics Inc?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Firmy z ebitda podobne do Acorda Therapeutics Inc
- Wartość EBITDA organizacji West High Yield (W.H.Y.) Resources to -CAD$4.09
- Wartość EBITDA organizacji Proactis Plc to -£4.09
- Wartość EBITDA organizacji CareTeQ to -AUD$4.09
- Wartość EBITDA organizacji General Moly to -$4.09
- Wartość EBITDA organizacji General Moly to -$4.09
- Wartość EBITDA organizacji General Moly to -$4.09
- Wartość EBITDA organizacji Acorda Therapeutics Inc to -$4.08
- Wartość EBITDA organizacji Ahsay Backup Software Development to -HKD$4.08
- Wartość EBITDA organizacji Manganese X to -CAD$4.08
- Wartość EBITDA organizacji Manganese X Corp to -CAD$4.08
- Wartość EBITDA organizacji Mega Uranium to -CAD$4.08
- Wartość EBITDA organizacji Krakatoa Resources to -AUD$4.07
- Wartość EBITDA organizacji Triumph Gold to -CAD$4.07